Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSichuan Provincial People's Hospital

About this trial

Prone Positioning in ARDS: Predicting Neurological Complications via Cerebral Hemodynamics

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age≥18 years

Meet the diagnostic criteria for ARDS(Acute Respiratory Distress Syndrome),with PaO₂/FiO₂<150 mmHg,and requiring prone ventilation

Expected duration of mechanical ventilation>48 hours

Written informed consent obtained

Disqualifiers

Presence of contraindications to prone positioning(e.g.,head and neck injuries,spinal instability,severe intracranial hypertension)

Severe neurological diseases(e.g.,cerebral hemorrhage,cerebral infarction,intracranial space-occupying lesions)that may affect the monitoring of cerebral hemodynamics

Life-threatening ARDS

Patients who are unable to undergo neurological assessment

Trial population

Patients with Moderate to Severe ARDS Expected to Undergo Mechanical Ventilation for Over 48 Hours

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Prone ventilation

    Behavioral

    Cerebral Blood Flow Monitoring Before and After Prone Ventilation in Patients with ARDS.Cerebral blood flow,intracranial pressure,and systemic hemodynamic monitoring were performed at the following time points:before prone positioning(T0),1 hour after prone ventilation(T1),12 hours after prone ventilation(T2),1 hour after returning to the supine position(T3),and 7 days after returning to the supine position(T4).

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Neuroimaging Studies

Cranial CT or MRI Scans Conducted Before and After Prone Positioning to Detect New-Onset Neurological Complications Such as Cerebral Edema, Intracranial Hemorrhage, and Cerebral Infarction

Time frame
From enrollment to 2 weeks after the end of treatment.
2

Biomarker Detection

Blood samples were collected for NSE(Neuron-specific Enolase)and IL-6(Interleukin-6)before and after prone positioning.

Time frame
From enrollment to 2 weeks after the end of treatment.

Secondary outcomes

1

Incidence rate of delirium

Assessment using the Confusion Assessment Method for the Intensive Care Unit(CAM-ICU)was conducted before and after prone position therapy in patients.

Time frame
From enrollment to 2 weeks after the end of treatment.
2

Cognitive function

Assessment using the Mini-Mental State Examination(MMSE)was conducted before and after prone position therapy in patients.

Time frame
From enrollment to 2 weeks after the end of treatment.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.